Devices

  Basel, Switzerland. September 10, 2025, 7am CEST     BV100: successful end of Phase 2 meeting with US FDA following Positive Phase 2 read-out in …

Word Count: 3,333 words, Reading Time: 15 minutes. Not financial advice, do your own due diligence, for entertainment purposes only. Subscribers: Substack is telling me this …

The issuer is solely responsible for the content of this announcement. Revenue increases by +12% compared to the second half of 2024 to €813.4 million (H2 …

GeneDx will face growing competition as the genomic diagnostics market attracts new entrants. However, its robust and expanding database —comprising over 850,000 sequenced exomes and genomes …

Word Count: 2,751 words, Reading Time: 13 minutes. Not financial advice, do your own due diligence, for entertainment purposes only. Hello readers, here is the third …

PharmaSGP Holding SE: Delisting of PharmaSGP shares from Frankfurt Stock Exchange effective upon the expiry of August 11, 2025 Disclosure of an inside information acc. to …

Word count: 5,014 words, Reading Time: 25 minutes Hi everyone, earnings season for me starts on Thursday so I wanted to get this preview out covering …

The issuer is solely responsible for the content of this announcement. Abivax Announces Launch of Public Offering  PARIS, France, July 23, 2025 – 10:15 p.m. (CEST) …

Word Count: 3,977 words, Reading Time: 19 minutes Note: Substack is telling me this post is too long for email. Subscribers, please view in browser if …

Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. PRESS RELEASE | AD …